Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

1800-272-662
Shopping Cart 0
countryflagAU
Login

Home CompaniesMEDIFAST INC

MEDIFAST INC

Consumer Cyclical Personal Services
PortfolioPortfolio WatchlistWatchlist
Company price
13.13 USD 0.10 ( 0.77%)
Last update at 2026-11-11T21:00:00Z
VOLUME
84950
Market Cap
742.44M
P/E
6.07

Momentum Score

…

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
13.02
Low
13.29
High
52 Week Price Range
61.94
Low
124.20
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Medifast, Inc. offers weight-management programs combining portion-controlled meals, nutritional products and independent coaches under its Optavia brand in the U.S. Long-term growth may be supported by obesity prevalence, repeat purchases from program participants and expansion of digital marketing. Investors may find the company attractive for its direct-to-consumer model, subscription-like revenue and brand recognition.

Material risks include intensifying competition from alternative weight-loss solutions including GLP‑1 drugs, reliance on coach-based distribution and U.S. market concentration, regulatory or legal scrutiny of sales practices, and supply-chain or consumer preference shifts.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
13.03
Dividend Yield
9.90%
Revenue TTM
1218.28M
Revenue Per Share
111.89
Gross Profit TTM
1140.41M
Debt / Equity
0.17
ROE
69.80%
Net Debt
-61.64M
ROCE
105.41%
Diluted EPS TTM
10.98

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax 184.06M 216.13M 134.26M 92.36M 70.55M
Net income 143.57M 164.03M 102.86M 77.92M 55.79M
Selling general administrative 955.61M 911.36M 563.66M 445.82M 310.84M
Gross profit 1140.41M 1127.60M 697.82M 536.86M 379.90M
Reconciled depreciation 10.98M 6.81M 7.27M 4.62M 4.43M
Ebit 184.81M 216.24M 126.89M 86.42M 64.63M
Ebitda 195.79M 223.05M 134.16M 91.04M 69.06M
Depreciation and amortization 10.98M 6.81M 7.27M 4.62M 4.43M
Non operating income net other -0.05M 0.12M -0.14M 0.03M 0.18M
Operating income 184.81M 216.24M 134.16M 91.04M 69.06M
Other operating expenses 1413.77M 1309.85M 800.68M 622.63M 431.94M
Interest expense 0.70M 0.11M 7.38M 5.95M 1.31M
Tax provision 40.49M 52.10M 31.41M 14.45M 14.76M
Interest income 0.70M 0.23M 0.25M 1.29M 1.31M
Net interest income -0.70M -0.23M 0.25M 1.29M 1.31M
Income tax expense 40.49M 52.10M 31.41M 14.45M 14.76M
Total revenue 1598.58M 1526.09M 934.84M 713.67M 501.00M
Total operating expenses 955.61M 911.36M 563.66M 445.82M 310.84M
Cost of revenue 458.16M 398.49M 237.03M 176.81M 121.10M
Total other income expense net -0.75M -0.11M 0.11M 1.32M 0.18M
Net income from continuing ops 143.57M 164.03M 102.86M 77.92M 55.79M
Net income applicable to common shares 143.57M 164.03M 102.86M 77.92M 55.79M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 316.21M 398.33M 276.08M 194.65M 169.43M
Other current assets 16.24M 17.28M 5.86M 11.27M 4.59M
Total liab 161.17M 195.85M 118.84M 89.82M 60.32M
Total stockholder equity 155.04M 202.47M 157.25M 104.83M 109.11M
Other current liab 69.09M 84.36M 64.30M 49.28M 38.51M
Common stock 0.01M 0.01M 0.01M 0.01M 0.01M
Capital stock 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings 139.85M 190.33M 154.35M 168.79M 131.34M
Other assets 17.78M 10.87M 14.14M 1.66M 4.16M
Cash 87.69M 104.18M 163.72M 76.97M 81.36M
Cash and equivalents 87.69M 104.18M 163.72M 76.97M 81.36M
Total current liabilities 140.89M 169.83M 111.35M 79.39M 60.32M
Current deferred revenue 7.36M 8.05M 7.61M 4.33M -
Net debt -61.64M -71.64M -152.56M -63.37M -81.36M
Short term debt 5.78M 6.52M 3.67M 3.17M 0.00M
Short long term debt total 26.05M 32.54M 11.16M 13.60M -
Other stockholder equity 15.16M 12.02M 2.84M -63.99M -22.08M
Property plant equipment 57.19M 56.13M 27.63M 26.04M 19.75M
Total current assets 222.78M 306.87M 234.31M 154.15M 145.52M
Net tangible assets 155.04M 202.47M 157.25M 104.83M 109.11M
Short term investments -0.02M 5.36M 10.75M 15.70M 19.67M
Net receivables - - 0.58M 1.44M 1.01M
Inventory 118.86M 180.04M 53.39M 48.77M 38.89M
Accounts payable 58.67M 70.89M 35.77M 22.61M 60.32M
Accumulated other comprehensive income 0.02M 0.11M 0.04M 0.03M -0.17M
Common stock total equity 0.01M 0.01M 0.01M 0.01M 0.01M
Retained earnings total equity 139.85M 190.33M 154.35M 168.79M 131.34M
Treasury stock - - -5.00M -63.99M -30.88M
Non currrent assets other 12.46M 6.47M 2.94M 0.35M 1.18M
Deferred long term asset charges - - - - 2.98M
Non current assets total 93.43M 91.46M 41.77M 40.50M 23.91M
Capital lease obligations 26.05M 32.54M 11.16M 13.60M -
Long term debt total 0.00M 0.00M 0.00M 0.00M 0.00M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments 5.27M 5.14M 4.61M 3.73M 3.54M
Change to liabilities -36.22M 54.38M 28.01M 12.11M 18.29M
Total cashflows from investing activities -11.41M -29.06M -1.28M -6.33M -1.20M
Total cash from financing activities -199.58M -125.13M -57.14M -82.32M -53.33M
Change to operating activities -3.31M -14.43M -2.27M -1.50M -0.22M
Net income 143.57M 164.03M 102.86M 77.92M 55.79M
Change in cash -16.49M -59.54M 86.75M -4.39M 6.29M
Begin period cash flow 104.18M 163.72M 76.97M 81.36M 75.08M
End period cash flow 87.69M 104.18M 163.72M 76.97M 81.36M
Total cash from operating activities 194.57M 94.55M 145.20M 84.26M 60.82M
Depreciation 10.98M 6.81M 7.27M 4.62M 4.43M
Other cashflows from investing activities 5.27M 5.14M 4.61M 3.73M 0.20M
Dividends paid 71.62M 63.86M 53.19M 35.40M 23.16M
Change to inventory 61.19M -126.65M -4.62M -9.88M -18.66M
Change to account receivables - - 0.30M -4.06M 0.12M
Sale purchase of stock -127.96M -62.09M -5.55M -47.21M -30.71M
Other cashflows from financing activities -11.41M 0.81M 1.60M 0.28M 0.55M
Change to netincome 12.26M 6.19M 8.16M 9.77M 0.49M
Capital expenditures 16.68M 34.21M 5.89M 10.06M 4.94M
Change receivables - - 0.30M -4.06M 0.12M
Cash flows other operating 2.78M -10.31M 2.90M -6.67M -0.22M
Exchange rate changes - - -0.02M 0.00M -0.00M
Cash and cash equivalents changes -16.43M -59.65M 86.75M -4.39M 6.29M
Change in working capital 21.65M -87.65M 26.58M -8.51M -0.47M
Stock based compensation 11.05M 9.90M 6.80M 4.52M 3.12M
Other non cash items 8.24M 5.16M 1.09M 4.11M 0.62M
Free cash flow 177.89M 60.34M 139.31M 74.20M 55.88M

Peer Comparison*

Sector: Consumer Cyclical Industry: Personal Services

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MED
MEDIFAST INC		 0.10
0.77%		 13.13 6.07 - 0.60 3.78 0.49 3.64
ROL
Rollins Inc		 -0.36
0.95%		 38.05 32.16 27.78 4.14 11.88 4.59 20.86
SCI
Service Corporation International		 1.04
1.40%		 75.40 21.26 17.61 2.53 7.21 3.69 12.18
ANDG
Andersen Group Inc.		 -0.13
0.20%		 65.64 126.07 - 6.71 - 7.24 -
HRB
H&R Block Inc		 -
-%		 50.99 8.06 7.26 1.43 47.99 1.72 6.42

Profile*

MEDIFAST INC

Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific. The company offers bars, bites, pretzels, puffs, cereal crunch, drinks, hearty choices, oatmeal, pancakes, pudding, soft serves, shakes, smoothies, soft bakes, and soups under the OPTAVIA, Optimal Health by Take Shape for Life, and Flavors of Home brands. It markets its products through point-of-sale transactions over ecommerce platform. The company was founded in 1980 and is based in Baltimore, Maryland.

100 International Drive, Baltimore, MD, United States, 21202

410 581 8042

https://medifastinc.com

874

Name Title Year Born
Mr. Daniel R. Chard Exec. Chairman & CEO 1965
Mr. James P. Maloney CPA Chief Financial Officer 1968
Mr. Anthony E. Tyree Chief Marketing Officer 1966
Mr. Nicholas M. Johnson Pres of Coach & Client Experience 1980
Ms. Lauren Walker Exec. VP of Supply Chain Operations 1967
Mr. Jonathan Barrett MacKenzie VP of Fin. & Chief Accounting Officer 1972
Mr. Jason L. Groves Esq. Exec. VP, Gen. Counsel & Corp. Sec. 1971
Ms. Claudia C. Greninger Exec. VP of HR 1973

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CU6
AUD 2.05
+23.49%
DMP
AUD 25.06
+12.93%
G6M
AUD 2.74
+10.93%
XRO
AUD 75.17
+6.08%
SGR
AUD 0.17
+6.06%
AXQ
AUD 3.07
-18.35%
BOE
AUD 1.50
-9.39%
GQG
AUD 0.71
-8.97%
MI6
AUD 0.81
-8.52%
ELV
AUD 3.73
-8.35%

Equity Sectors*

  • Basic Materials

    -3.09%

  • Communication Services

    +0.75%

  • Consumer Cyclical

    +0.43%

  • Consumer Defensive

    +0.12%

  • Energy

    -1.07%

  • Financial Services

    -0.02%

  • Healthcare

    +1.08%

  • Industrials

    -0.22%

  • Real Estate

    +0.61%

  • Technology

    -1.69%

  • Utilities

    -0.18%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…